Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fortress Biotech (FBIO) Total Liabilities: 2013-2025

Historic Total Liabilities for Fortress Biotech (FBIO) over the last 13 years, with Sep 2025 value amounting to $116.2 million.

  • Fortress Biotech's Total Liabilities fell 16.88% to $116.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $116.2 million, marking a year-over-year decrease of 16.88%. This contributed to the annual value of $145.9 million for FY2024, which is 12.10% down from last year.
  • Fortress Biotech's Total Liabilities amounted to $116.2 million in Q3 2025, which was down 5.13% from $122.5 million recorded in Q2 2025.
  • Fortress Biotech's 5-year Total Liabilities high stood at $244.3 million for Q4 2022, and its period low was $116.2 million during Q3 2025.
  • In the last 3 years, Fortress Biotech's Total Liabilities had a median value of $160.3 million in 2024 and averaged $160.8 million.
  • As far as peak fluctuations go, Fortress Biotech's Total Liabilities skyrocketed by 63.17% in 2021, and later slumped by 32.07% in 2023.
  • Over the past 5 years, Fortress Biotech's Total Liabilities (Quarterly) stood at $170.6 million in 2021, then surged by 43.16% to $244.3 million in 2022, then tumbled by 32.07% to $165.9 million in 2023, then declined by 12.10% to $145.9 million in 2024, then declined by 16.88% to $116.2 million in 2025.
  • Its Total Liabilities was $116.2 million in Q3 2025, compared to $122.5 million in Q2 2025 and $145.6 million in Q1 2025.